Short Interest in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Increases By 92.3%

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the recipient of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 877 shares, an increase of 92.3% from the July 15th total of 456 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 1,618 shares, the days-to-cover ratio is currently 0.5 days.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Susquehanna International Group LLP boosted its position in Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares during the period. Comprehensive Wealth Management LLC raised its position in shares of Innovator IBD Breakout Opportunities ETF by 122.0% in the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares during the period. Finally, Osaic Holdings Inc. lifted its stake in shares of Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after buying an additional 597 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Price Performance

Shares of NYSEARCA BOUT traded up $0.56 during trading on Monday, reaching $45.26. 747 shares of the stock traded hands, compared to its average volume of 3,870. Innovator IBD Breakout Opportunities ETF has a 52-week low of $35.05 and a 52-week high of $49.41. The company has a 50-day moving average of $46.85 and a 200-day moving average of $43.77. The stock has a market capitalization of $15.84 million, a P/E ratio of 28.69 and a beta of 1.04.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.